prostate-report.org

China study: PSA screening is effective for early detection of prostate cancer

As previous studies have suggested that implementation of PSA screening in China is of crucial importance, a recent study at Nanjing Medical University, China, compared clinical and pathological characteristics of screen-detected and clinically diagnosed prostate cancers and evaluated the effectiveness of PSA screening for early detection of prostate cancer in Nanjing.

The study concluded that PSA screening is effective for early detection of prostate cancer in Chinese elderly men. Favorable PSA levels, Gleason scores, clinical stages, and chances for radical prostatectomy are associated with PSA screening. Further studies are needed to evaluate the effect of screening on treatment outcomes and mortality of prostate cancer in Chinese.

Of course, if prostate cancer screening becomes commonplace in China, the world’s most populous nation will also have to face up to the question of the most appropriate way to manage men with early-stage, screen-detected prostate cancer.